Glenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food & Drug Administration (U.

S. FDA) for Fluocinolone Acetonide Oil, 0.01% (Ear Drops), a generic version of DermOtic1 Oil, 0.01% (Ear Drops), of Hill Dermaceuticals, Inc.

According to IQVIA sales data for the 12 month period ending October 2018, the DermaOtic Oil, 0.01% (Ear Drops) market2 achieved annual sales of approximately $18.1 million.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)